Mark Traynor

Ex-financial adviser who now writes about retirement planning, tax-efficient saving, and the math of long-term wealth.

Articles by Mark Traynor

Latest Posts

Crypto

XRP Hits Potential Bottom: Signs Bulls May Seize Control

XRP has staged a remarkable 50% rebound, climbing to a peak of $1.67 after touching a 15-month trough at $1.12

Read

Personal Finance

Why Most Retirees Cannot Access Social Security's Maximum Benefit

Why Achieving the Highest Social Security Payments Can Be DifficultThe typical monthly retirement payment distributed through Social Security currently averages around $2,084. While this figure might appear modest to some individuals, it truly represents a limited annual income of roughly $25,000 fo

Read

Business

Snap CTO Offloads 2M Shares Amid Record Stock Low

Snap’s Chief Technology Officer Executes Major Share Sale During Historic Stock Decline Snap, once celebrated as a leading player in

Read

Investing

2025 Cybersecurity Leaders: 2026 Winners Ahead?

Cybersecurity Stocks Excelled in 2025: 2026 Opportunities Shares of numerous cybersecurity firms experienced substantial gains throughout 2025, propelled by artificial

Read

Business

Analysts Upgrade PEP, ABBV, UPS for 2026 Growth

3 Dividend Growth Stocks Analysts Are Upgrading for 2026 Individual analyst ratings and consensus price targets hold limited significance for

Read

Business

Goodwin: Top UK Engineer Worth Premium Shares

Looking for evidence that British manufacturing remains vibrant? Visit an understated area in Stoke-on-Trent. There, on a site occupied since

Read

Investing

Buffett’s Last Moves: Sells Amazon, Apple, BofA; Buys NYT Stock Pre-Retirement

The Oracle of Omaha’s Final Quarter as Berkshire Hathaway CEO Quarterly Form 13F filings submitted to the Securities and Exchange

Read

Personal Finance

Dave Ramsey’s Urgent Debt Payoff Plan for Over-50s

Transitioning from employment to retirement brings a mix of excitement and apprehension, particularly when lingering debts remain unsettled. Those entering

Read

Investing

$300 Buys 2 Biotech Stocks for Long-Term Gains

Promising Biotech Opportunities with Blockbuster Potential Two innovative biotechnology companies, each equipped with a single commercialized therapy, stand out due

Read